Blumen-Ohana Esther

Leleu Igor, Penaud Benjamin, Blumen-Ohana Esther, Rodallec Thibault, Adam Raphaël, Laplace Olivier et al.

This study found non-penetrating deep sclerectomy for severe/end-stage glaucoma did not cause "wipe-out" (sudden vision loss). This suggests NPDS is a safe option for these patients, reducing apprehension about this complication.

Penaud Benjamin, Leleu Igor, Laplace Olivier, Akesbi Jad, Blumen-Ohana Esther, Nordmann Jean-Philippe

Laser goniopuncture (LGP) frequently lowers intraocular pressure after deep sclerectomy, achieving target pressures in 50% of cases for two years, but carries a risk of iris incarceration.

Leleu Igor, Penaud Benjamin, Blumen-Ohana Esther, Rodallec Thibault, Adam Raphaël, Laplace Olivier et al.

NPDS in severe glaucoma stabilized central visual fields and lowered IOP without sudden vision loss, suggesting it's a safe option for preserving remaining vision.

Moyal Laura, Blumen-Ohana Esther, Blumen Marc, Blatrix Cybele, Chabolle Frederic, Nordmann Jean-Philippe

This study found OCTA did not detect reduced optic nerve or macular vessel density in OSAS patients. This suggests OSAS-related optic nerve damage may not be primarily due to large vessel density changes.

Aptel Florent, Charrel Thomas, Lafon Cyril, Romano Fabrice, Chapelon Jean-Yves, Blumen-Ohana Esther et al.

This pilot study found a miniaturized HIFU device safely and effectively lowered intraocular pressure in refractory glaucoma patients, suggesting a promising new treatment option.